Skip to main content

Advertisement

SpringerLink
Log in

Is high-dose cholecalciferol justified in children with chronic kidney disease who failed low-dose maintenance therapy?

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

We aimed to investigate the effect of single, high-dose intramuscular cholecalciferol on vitamin D3 and intact parathyroid hormone (iPTH) levels in children with chronic kidney disease (CKD).

Methods

Between January 2012 and June 2012, we conducted a prospective, uncontrolled study at the Pediatric Nephrology Unit of King Abdulaziz University Hospital, Jeddah, to investigate the effect of single, high-dose intramuscular vitamin D3 on 25(OH)D3 and iPTH levels in vitamin D insufficient/deficient children with CKD. Serum vitamin D3, iPTH, calcium, phosphate, alkaline phosphatase (ALP), and creatinine levels were measured before intramuscular vitamin D3 (300,000 IU) administration, and these were subsequently repeated at 1 and 3 months after treatment. Statistical analysis was performed with the Statistical Package for the Social Sciences (SPSS Inc., Chicago, IL, USA).

Results

Nineteen children fulfilled the criteria. At 3 months after treatment, vitamin D3 levels were significantly higher than at baseline (p < 0.001) but lower than the levels at 1 month. iPTH levels decreased significantly at 3 months (p = 0.01); however, the drop in iPTH levels was not significant at 1 month (p = 0.447). There were no changes in calcium, phosphate, ALP, or creatinine levels after treatment.

Conclusions

Single-dose intramuscular vitamin D3 (300,000 IU) resulted in significant improvement of vitamin D3 and iPTH levels in children with CKD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bacchetta J, Harambat J, Cochat P, Salusky IB, Wesseling-Perry K (2012) The consequences of chronic kidney disease on bone metabolism and growth in children. Nephrol Dial Transplant 27(8):3063–3071

    Article  PubMed  CAS  Google Scholar 

  2. Sanchez CP (2008) Mineral metabolism and bone abnormalities in children with chronic renal failure. Rev Endocr Metab Disord 9(2):131–137

    Article  PubMed  CAS  Google Scholar 

  3. Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR et al (2000) Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 58(1):396–399

    Article  PubMed  CAS  Google Scholar 

  4. Rucker D, Tonelli M, Coles MG, Yoo S, Young K, McMahon AW (2009) Vitamin D insufficiency and treatment with oral vitamin D3 in northern-dwelling patients with chronic kidney disease. J Nephrol 22(1):75–82

    PubMed  CAS  Google Scholar 

  5. Holden RM, Morton AR, Garland JS, Pavlov A, Day AG, Booth SL (2010) Vitamins K and D status in stages 3–5 chronic kidney disease. Clin J Am Soc Nephrol 5(4):590–597

    Article  PubMed  CAS  Google Scholar 

  6. Jabbar Z, Aggarwal PK, Chandel N, Kohli HS, Gupta KL, Sakhuja V, Jha V (2009) High prevalence of vitamin D deficiency in north Indian adults is exacerbated in those with chronic kidney disease. Nephrology (Carlton) 14(3):345–349

    Article  CAS  Google Scholar 

  7. Belostotsky V, Mughal MZ, Berry JL, Webb NJ (2008) Vitamin D deficiency in children with renal disease. Arch Dis Child 93(11):959–962

    Article  PubMed  CAS  Google Scholar 

  8. Menon S, Valentini RP, Hidalgo G, Peschansky L, Mattoo TK (2008) Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease. Pediatr Nephrol 23(10):1831–1836

    Article  PubMed  Google Scholar 

  9. Kari JA, El-Desouky SM, EL-Morshedy SM, Habib HS (2012) Vitamin D insufficiency and deficiency in children with chronic kidney disease. Annals Saudi Med 32(5):473–478

    Google Scholar 

  10. Moe SM, Drüeke TB, Block GA, Cannata-Andía JB, Elder GJ, Fukagawa M, Jorgetti V, Ketteler M, Langman CB, Levin A, MacLeod AM, McCann L, McCullough PA, Ott SM, Wang AY, Weisinger JR, Wheeler DC, Persson R, Earley A, Moorthi R, Uhlig K (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (113):S1–130

  11. Shroff R, Wan M, Gullett A, Ledermann S, Shute R, Knott C, Wells D, Aitkenhead H, Manickavasagar B, van’t Hoff W, Rees L (2012) Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial. Clin J Am Soc Nephrol 7(2):216–223

    Article  PubMed  CAS  Google Scholar 

  12. Kari JA, Eldesoky SM, Bagdadi OT (2012) Vitamin D insufficiency and treatment with oral vitamin D3 in children with chronic kidney disease. Saudi Med J 33(7):740–744

    PubMed  Google Scholar 

  13. Kemperman FA, Krediet RT, Arisz L (2002) Formula-derived prediction of the glomerular filtration rate from plasma creatinine concentration. Nephron 91(4):547–558

    Article  PubMed  CAS  Google Scholar 

  14. Al-Atawi MS, Al-Alwan IA, Al-Mutair AN, Tamim HM, Al-Jurayyan NA (2009) Epidemiology of nutritional rickets in children. Saudi J Kidney Dis Transpl 20:260–265

    PubMed  CAS  Google Scholar 

  15. Al-Jurayyan NA, El-Desouki ME, Al-Herbish AS, Al-Mazyad AS, Al-Qhtani MM (2002) Nutritional rickets and osteomalacia in school children and adolescents. Saudi Med J 23:182–185

    PubMed  Google Scholar 

  16. Libuda L, Alexy U, Remer T, Stehle P, Schoenau E, Kersting M (2008) Association between long-term consumption of soft drinks and variables of bone modeling and remodeling in a sample of healthy German children and adolescents. Am J Clin Nutr 88:1670–1677

    Article  PubMed  CAS  Google Scholar 

  17. Hari P, Gupta N, Hari S, Gulati A, Mahajan P, Bagga A (2010) Vitamin D insufficiency and effect of cholecalciferol in children with chronic kidney disease. Pediatr Nephrol 25(12):2483–2488

    Article  PubMed  Google Scholar 

  18. Belostotsky V, Mughal Z, Webb NJ (2009) A single high dose of ergocalciferol can be used to boost 25-hydroxyvitamin D levels in children with kidney disease. Pediatr Nephrol 24(3):625–626

    Article  PubMed  Google Scholar 

  19. Munns C, Zacharin MR, Rodda CP, Batch JA, Morley R, Cranswick NE, Craig ME, Cutfield WS, Hofman PL, Taylor BJ, Grover SR, Pasco JA, Burgner D, Cowell CT, Paediatric Endocrine Group, Paediatric Bone Australasia (2006) Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement. Med J Aust 185(5):268–272

    Google Scholar 

  20. Carnes J, Quinn S, Nelson M, Jones G, Winzenberg T (2011) Intermittent high-dose vitamin D corrects vitamin D deficiency in adolescents: a pilot study. Eur J Clin Nutr 66(4):530–532

    Article  PubMed  Google Scholar 

  21. Geary DF, Hodson EM, Craig JC (2010) Interventions for bone disease in children with chronic kidney disease. Cochrane Database Syst Rev (1):CD008327. doi:10.1002/14651858.CD008327

  22. KDOQI Work Group (2009) KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary. Am J Kidney Dis 53(3 Suppl 2):S11–104

  23. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M (2008) Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 122(2):398–417

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, King Abdulaziz University, PO Box 80215, Jeddah, 21589, Kingdom of Saudi Arabia

    Jameela Abdulaziz Kari, Osama T. Baghdadi & Sherif El-Desoky

Authors
  1. Jameela Abdulaziz Kari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Osama T. Baghdadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sherif El-Desoky
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jameela Abdulaziz Kari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kari, J.A., Baghdadi, O.T. & El-Desoky, S. Is high-dose cholecalciferol justified in children with chronic kidney disease who failed low-dose maintenance therapy?. Pediatr Nephrol 28, 933–937 (2013). https://doi.org/10.1007/s00467-012-2407-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-012-2407-2

Keywords

Search

Navigation